[Transfusion safety, time for a new partnership between stake-holders].

Transfusion safety, time for a new partnership between stake-holders Following heightened publicity surrounding contaminated blood products, increased control has been implemented concerning all aspects of transfusion, from blood donor to finished product. A quality control programme has been implemented allowing a substantial reduction in adverse events. Transfusion medicine mandates the application of safety measures and hemo-vigilance helps to identify major risk factors in relation to bedside processes.